Holen Sie sich die Stockscreener-App
2.50
0.00%
0.00
Handel nachbörslich:
2.53
0.03
+1.20%
Schlusskurs vom Vortag:
$2.50
Offen:
$2.54
24-Stunden-Volumen:
3.35M
Relative Volume:
0.93
Marktkapitalisierung:
$578.64M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-179.82M
KGV:
-1.8797
EPS:
-1.33
Netto-Cashflow:
$-159.16M
1W Leistung:
-13.19%
1M Leistung:
-27.54%
6M Leistung:
+83.82%
1J Leistung:
+138.10%
1-Tages-Spanne:
$2.41
$2.61
1-Wochen-Bereich:
$2.35
$2.9699
52-Wochen-Spanne:
$0.76
$3.87
Gossamer Bio Inc Stock (GOSS) Company Profile
Firmenname
Gossamer Bio Inc
Sektor
Branche
Telefon
(858) 684-1300
Adresse
3115 MERRYFIELD ROW, SAN DIEGO, CA
Vergleichen Sie GOSS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GOSS
Gossamer Bio Inc
|
2.50 | 578.64M | 0 | -179.82M | -159.16M | -1.33 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Gossamer Bio Inc Stock (GOSS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-10 | Hochstufung | UBS | Neutral → Buy |
| 2025-07-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-04-05 | Fortgesetzt | Wedbush | Outperform |
| 2023-07-27 | Herabstufung | UBS | Buy → Neutral |
| 2023-03-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-03-01 | Eingeleitet | Guggenheim | Neutral |
| 2022-12-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-12-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-12-07 | Herabstufung | SMBC Nikko | Outperform → Neutral |
| 2022-10-20 | Eingeleitet | Goldman | Buy |
| 2022-09-21 | Eingeleitet | JP Morgan | Neutral |
| 2022-09-19 | Eingeleitet | Wedbush | Outperform |
| 2022-04-18 | Eingeleitet | Raymond James | Outperform |
| 2022-04-06 | Eingeleitet | UBS | Buy |
| 2022-01-10 | Hochstufung | SMBC Nikko | Neutral → Outperform |
| 2021-11-09 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-09-21 | Fortgesetzt | Piper Sandler | Overweight |
| 2020-06-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-04-22 | Eingeleitet | Piper Sandler | Overweight |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2019-12-03 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-10-30 | Eingeleitet | Berenberg | Buy |
| 2019-03-05 | Eingeleitet | Barclays | Overweight |
| 2019-03-05 | Eingeleitet | BofA/Merrill | Buy |
| 2019-03-05 | Eingeleitet | Evercore ISI | Outperform |
| 2019-03-05 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Gossamer Bio Inc Aktie (GOSS) Neueste Nachrichten
Is Gossamer Bio Inc. stock trading at a premium valuation2025 Winners & Losers & High Accuracy Investment Signals - ulpravda.ru
How Gossamer Bio Inc. (4GB) stock reacts to stronger dollarTrade Analysis Report & AI Powered Market Entry Ideas - ulpravda.ru
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Can Gossamer Bio Inc. stock hit record highs againJuly 2025 Macro Moves & Weekly Setup with High ROI Potential - ulpravda.ru
Gossamer Bio Sees Unusually High Options Volume (NASDAQ:GOSS) - Defense World
Gossamer Bio Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since November 2024 -- Data Talk - 富途牛牛
The Truth About Gossamer Bio Inc (GOSS): Tiny Stock, Massive Drama – Is It Worth the Hype? - AD HOC NEWS
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 3.6%What's Next? - MarketBeat
Gossamer Bio Inc 4GB Stock Analysis and ForecastHigh Dividend Yield Stocks & Free Expert Stock Watchlists - earlytimes.in
Gossamer Bio (GOSS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Gossamer Bio: Market Moves and Future Prospects - StocksToTrade
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 4.1%Should You Sell? - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Shares Up 9.2%Here's Why - MarketBeat
Gossamer Bio, Inc.(NasdaqGS: GOSS) added to S&P Biotechnology Select Industry Index - marketscreener.com
Gap Down: Will Timberland Bancorp Inc stock outperform Nasdaq indexJuly 2025 Earnings & Low Volatility Stock Recommendations - moha.gov.vn
Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data - Finviz
Corient Private Wealth LLC Purchases 302,200 Shares of Gossamer Bio, Inc. $GOSS - MarketBeat
Aug Decliners: Can Gossamer Bio Inc. stock deliver surprise earnings beatWeekly Profit Recap & Expert Curated Trade Setups - Улправда
Is Gossamer Bio Inc. stock attractive for income investorsJuly 2025 Closing Moves & Free Weekly Watchlist of Top Performers - DonanımHaber
Gossamer Bio: High Risk Binary Approaches (NASDAQ:GOSS) - Seeking Alpha
Will Gossamer Bio Inc. stock reach Wall Street targetsJuly 2025 Highlights & Low Risk High Reward Ideas - DonanımHaber
Gossamer Bio, Inc. (NASDAQ:GOSS) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Can Gossamer Bio Inc. stock deliver surprise earnings beatJuly 2025 Setups & Free Daily Entry Point Trade Alerts - Улправда
Gossamer Bio (NASDAQ:GOSS) Sets New 1-Year HighShould You Buy? - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Stock Price Down 6.5%Time to Sell? - MarketBeat
Oppenheimer Confident in Positive PROSERA Trial Readout in February 2026 for Gossamer Bio (GOSS) - Finviz
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.1%Here's What Happened - MarketBeat
20 Stocks That Will Double in 2026 - Insider Monkey
Gossamer Bio (NASDAQ:GOSS) Hits New 52-Week HighShould You Buy? - MarketBeat
Gossamer Bio (NASDAQ:GOSS) Hits New 1-Year HighTime to Buy? - MarketBeat
Gossamer Bio announces inducement grant under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Gossamer Bio Inc (GOSS) is looking forward to a strong quarter - setenews.com
Gossamer Bio (NASDAQ:GOSS) Stock Price Up 5.9%Still a Buy? - MarketBeat
Is Gossamer Bio Stock Built to Withstand a Pullback? - Trefis
Gossamer Bio, Inc. (GOSS) Stock Analysis: Unveiling A 177.78% Potential Upside - DirectorsTalk Interviews
What RSI levels show for Gossamer Bio Inc. (4GB) stockJuly 2025 Retail & Risk Adjusted Swing Trade Ideas - Newser
Adversity is less terrifying than hope: Gossamer Bio Inc (GOSS) - setenews.com
Why millennials buy Gossamer Bio Inc. (4GB) stockJuly 2025 Analyst Calls & Precise Buy Zone Tips - Newser
Will Gossamer Bio Inc. stock maintain growth storyJuly 2025 Patterns & Community Supported Trade Ideas - Newser
How Recent Developments Are Shaping the Gossamer Bio Investment Story - Yahoo Finance
Gossamer Bio, Inc. (GOSS) Stock Analysis: Exploring a 184% Potential Upside in the Biotechnology Sector - DirectorsTalk Interviews
Gossamer Bio, Inc.'s (NASDAQ:GOSS) 28% Share Price Surge Not Quite Adding Up - simplywall.st
Gossamer Bio to Participate in Upcoming December 2025 Investor Conferences - BioSpace
Gossamer Bio to Participate in Upcoming Investor Conferences - Enidnews.com
Analysts Offer Predictions for Gossamer Bio FY2025 Earnings - MarketBeat
GOSS News Today | Why did Gossamer Bio stock go down today? - MarketBeat
How Gossamer Bio Inc. (4GB) stock reacts to fiscal policiesWeekly Trend Summary & Consistent Growth Equity Picks - newser.com
How Gossamer Bio Inc. (4GB) stock moves in volatile trading sessionsMarket Risk Analysis & Stock Portfolio Risk Management - newser.com
Finanzdaten der Gossamer Bio Inc-Aktie (GOSS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):